Chronic Kidney Disease - Another Step Forward

Affiliations

¹ From the Division of Nephrology and Hypertension, Departments of Medicine and Transplantation Medicine, Weill Cornell Medicine, and the Theresa Lang Center for Research and Education, New York-Presbyterian Hospital, New York.

Editorial

Phyllis August. N Engl J Med. 2023.

. 2023 Jan 12;388(2):179-180.

doi: 10.1056/NEJMe2215286.

¹ From the Division of Nephrology and Hypertension, Departments of Medicine and Transplantation Medicine, Weill Cornell Medicine, and the Theresa Lang Center for Research and Education, New York-Presbyterian Hospital, New York.

No abstract available

Comment on

Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.